AstraZeneca is paying insitro $40 million upfront to find liver and heart drug targets Oct 15, 2026 · Cris Tolomia Insitro is eligible for up to about $1.46 billion in milestone payments, plus single-digit royalties on global sales Read more »
.jpg?branch=production)
